Fundamentals and Catalytic Innovation: The Statistical and Data Management Center of the Antibacterial Resistance Leadership Group.
Authors:
Open Access
- 2 March 2017
- journal article
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 64 (suppl_1) , S18-S23
Abstract
The Statistical and Data Management Center (SDMC) provides the Antibacterial Resistance Leadership Group (ARLG) with statistical and data management expertise to advance the ARLG research agenda. The SDMC is active at all stages of a study, including design; data collection and monitoring; data analyses and archival; and publication of study results. The SDMC enhances the scientific integrity of ARLG studies through the development and implementation of innovative and practical statistical methodologies and by educating research colleagues regarding the application of clinical trial fundamentals. This article summarizes the challenges and roles, as well as the innovative contributions in the design, monitoring, and analyses of clinical trials and diagnostic studies, of the ARLG SDMC.Keywords
This publication has 23 references indexed in Scilit:
- Leading Antibacterial Laboratory Research by Integrating Conventional and Innovative Approaches: The Laboratory Center of the Antibacterial Resistance Leadership GroupClinical Infectious Diseases, 2017
- The Role of Stewardship in Addressing Antibacterial Resistance: Stewardship and Infection Control Committee of the Antibacterial Resistance Leadership GroupClinical Infectious Diseases, 2017
- Informing Antibiotic Treatment Decisions: Evaluating Rapid Molecular Diagnostics To Identify Susceptibility and Resistance to Carbapenems against Acinetobacter spp. in PRIMERS IIIJournal of Clinical Microbiology, 2017
- Using Outcomes to Analyze Patients Rather than Patients to Analyze Outcomes: A Step Toward Pragmatism in Benefit:Risk EvaluationStatistics in Biopharmaceutical Research, 2016
- Methods and issues in studies of CREVirulence, 2016
- Rapid Molecular Diagnostics, Antibiotic Treatment Decisions, and Developing Approaches to Inform Empiric Therapy: PRIMERS I and IIClinical Infectious Diseases, 2015
- Alternatives to Hazard Ratios for Comparing the Efficacy or Safety of Therapies in Noninferiority StudiesAnnals of Internal Medicine, 2015
- Editorial Commentary: A Chance to Change the Paradigm of Outcome Assessment of Antimicrobial Stewardship Programs: Figure 1.Clinical Infectious Diseases, 2015
- Sample size determination in group‐sequential clinical trials with two co‐primary endpointsStatistics in Medicine, 2014
- Predicted Interval Plots (PIPS): A Graphical Tool for Data Monitoring of Clinical TrialsStatistics in Biopharmaceutical Research, 2009